The impact of background liver disease on the long-term prognosis of very-early-stage HCC after ablation therapy.

Kenta TakauraMasayuki KurosakiKento InadaSakura KirinoKouji YamashitaTomohiro MutoLeona OsawaShuhei SekiguchiYuka HayakawaMayu HiguchiShun KanekoChiaki MaeyashikiNobuharu TamakiYutaka YasuiJun ItakuraKaoru TsuchiyaHiroyuki NakanishiYuka TakahashiNamiki Izumi

Published in: PloS one (2022)

The prognosis of RFA treatment for very early-stage HCC was favorable. Achieving SVR in hepatitis C was important for further prognosis improvement.

Keyphrases

early stage
radiofrequency ablation
sentinel lymph node
stem cells
squamous cell carcinoma
lymph node
mesenchymal stem cells
rectal cancer
neoadjuvant chemotherapy